BCL2: A promising cancer therapeutic target
Author:
Funder
IISc-DBT
Publisher
Elsevier BV
Subject
Cancer Research,Genetics,Oncology
Reference59 articles.
1. A review on various targeted anticancer therapies;Li;Target. Oncol.,2012
2. Targeted cancer therapy;Sawyers;Nature,2004
3. Strategies for optimizing combinations of molecularly targeted anticancer agents;Dancey;Nat. Rev. Drug Discov.,2006
4. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance;Zitvogel;Immunity,2013
5. FDA approval summary: olaparib monotherapy in patients with deleterious germline BRCA-mutated advanced ovarian cancer treated with three or more lines of chemotherapy;Kim;Clin. Cancer Res.,2015
Cited by 115 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthesis, molecular docking, molecular dynamics and ADMET prediction studies of novel (S)-Verbenone-Arylidene -Isoxazoline hybrids;Journal of Molecular Structure;2024-12
2. Myrtenol ameliorates inflammatory, oxidative, apoptotic, and hyperplasic effects of urethane-induced atypical adenomatous hyperplasia in the rat lung;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-23
3. A novel approach toward the multigram synthesis of a novel Bcl2-specific inhibitor, and evaluation of its biological activity;European Journal of Medicinal Chemistry Reports;2024-08
4. Magnetothermal-activated gene editing strategy for enhanced tumor cell apoptosis;Journal of Nanobiotechnology;2024-07-30
5. Biflavonoids: Preliminary Reports on Their Role in Prostate and Breast Cancer Therapy;Pharmaceuticals;2024-07-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3